Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02730650 · ClinicalTrials.gov registry record · NA
Platelet Rich Therapy for Facial Rejuvenation
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02730650 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 30 participants.
The verdict
NCT02730650, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study will be a prospective study of patients who undergo platelet-rich therapy (PRT) for facial rejuvenation at NYU Langone Medical Center. PRT has been increasingly used for wound healing, fat grafting, hemostasis as well as facial enhancement. PRT involves injection of patient's own platelets and fibrin, and has evolved as a less invasive technique for facial rejuvenation compared to more traditional techniques. Through the use of pre and post treatment photos, in addition to the FACE-Q Questionnaire and a clinician assessment, it is our hope that we will confirm the rejuvenating capabilities of PRT.
Interventions
- OTHER Platelet Rich Therapy (PRT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-12-31 |
| Est. Completion | 2017-12-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02730650
The ClinicalTrials.gov registry entry for NCT02730650 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Platelet Rich Therapy (PRT) is the first listed.
NCT02730650 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02730650 about?
NCT02730650 is a clinical study titled "Platelet Rich Therapy for Facial Rejuvenation". This study will be a prospective study of patients who undergo platelet-rich therapy (PRT) for facial rejuvenation at NYU Langone Medical Center. PRT has been increasingly used for wound healing, fat grafting, hemostasis as well as facial enhancement. PRT involves injection of patient's own platelet...
What is the current status of trial NCT02730650?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-12-31. Estimated completion is 2017-12-28.
What interventions are being tested in trial NCT02730650?
The interventions under investigation include: Platelet Rich Therapy (PRT) (OTHER).
Who is sponsoring clinical trial NCT02730650?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.